The integration of single-cell RNA sequencing and spatial transcriptomics reveals the tumor microenvironment and spatial organization of testicular diffuse large B-cell lymphomas.

in Genes & diseases by Xiaolong Wu, Jie Shi, Mujun Lu, Damin Yun, Sheng Gao, Longfei Hu, Fei Sun

TLDR

  • The study investigated the tumor microenvironment and spatial organization of primary testicular DLBCL, identifying key transcription factors and genes involved in cell proliferation and development.

Abstract

Primary testicular diffuse large B-cell lymphomas (PT-DLBCL) are a collection of 1%-9% of testicular tumors. However, the characterization of the tumor microenvironment and spatial organization of PT-DLBCL is poorly understood. We profiled the transcriptomes of 19,559 single cells derived from a PT-DLBCL patient via single-cell RNA sequencing. We found that the tumor microenvironment was majorly composed of three exhausted CD8T cell subpopulations and two B cell subpopulations, and the genetic heterogeneity was further analyzed. Then, transcription factors related to PT-DLBCL cell proliferation and development were identified. Our results demonstrated that inhibiting E2F and CREB could decrease cell proliferation, induce apoptosis in human B-lymphoma cells, and inhibit tumor growth in xenograft testicular DLBCL models. Subsequently, chromatin immunoprecipitation sequencing was performed to identify the enriched loci of E2F and CREB that regulate human B-lymphoma cell proliferation and apoptosis. To annotate the precise spatial cellular composition of testicular DLBCL, we performed spatial transcriptomics. The spatial organization of PT-DLBCL, especially the spatial location of exhausted CD8T and B cells, was identified. Concurrently, we delineated the expression patterns of key genes, including MALAT1, RPS3A, RPS7, RPS23, RPS27A, IGHM, HINT1, and HSPA8, across various regions. In this study, we unveiled the spatial architecture of the tumor microenvironment in DLBCL, where exhausted T cells were strategically positioned around tumor B cells, and macrophages, in turn, encircled the exhausted T cells. Inhibition of E2F and CREB in the tumor microenvironment may be a novel therapeutic option for testicular DLBCL patients.

Overview

  • The study aimed to characterize the tumor microenvironment and spatial organization of primary testicular diffuse large B-cell lymphoma (PT-DLBCL), a rare type of testicular tumor.
  • The researchers used single-cell RNA sequencing to analyze the transcriptomes of 19,559 cells derived from a PT-DLBCL patient.
  • The primary objective of the study was to identify key transcription factors and genes involved in PT-DLBCL cell proliferation, development, and potential therapeutic targets.

Comparative Analysis & Findings

  • The study identified three exhausted CD8T cell subpopulations and two B cell subpopulations as the major components of the tumor microenvironment, with significant genetic heterogeneity.
  • The researchers found that inhibiting E2F and CREB transcription factors decreased cell proliferation, induced apoptosis in human B-lymphoma cells, and inhibited tumor growth in xenograft testicular DLBCL models.
  • Spatial transcriptomics revealed the precise spatial cellular composition of testicular DLBCL, showing exhausted CD8T and B cells in a strategic location around tumor B cells and macrophages encircling exhausted T cells.

Implications and Future Directions

  • The study's findings suggest that inhibiting E2F and CREB transcription factors may be a novel therapeutic option for testicular DLBCL patients.
  • Future research could focus on exploring the therapeutic potential of E2F and CREB inhibition in combination with other treatments, as well as investigating the specific role of genes like MALAT1, RPS3A, and IGHM in PT-DLBCL.
  • Elucidating the mechanisms of chromatin modification and epigenetic regulation in PT-DLBCL could provide new insights into the pathophysiology of this rare disease.